H. B. Fuller (FUL) Expected to Announce Quarterly Earnings on Wednesday

H. B. Fuller (NYSE:FUL) is expected to announce its Q4 2025 results after the market closes on Wednesday, January 14th. Analysts expect the company to announce earnings of $1.24 per share and revenue of $901.34 million for the quarter. H. B. Fuller has set its FY 2022 guidance at $4.100-$4.350 EPS. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, January 15, 2026 at 10:30 AM ET.

H. B. Fuller (NYSE:FUL) last issued its quarterly earnings results on Wednesday, April 13th. The specialty chemicals company reported $0.66 earnings per share (EPS) for the quarter. H. B. Fuller had a return on equity of 11.49% and a net margin of 3.28%.The firm had revenue of $725.90 million during the quarter. On average, analysts expect H. B. Fuller to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

H. B. Fuller Stock Performance

Shares of H. B. Fuller stock opened at $61.64 on Wednesday. The stock’s fifty day moving average is $58.69 and its two-hundred day moving average is $59.45. The company has a market capitalization of $3.33 billion, a PE ratio of 33.32, a price-to-earnings-growth ratio of 0.97 and a beta of 1.10. The company has a quick ratio of 1.18, a current ratio of 1.93 and a debt-to-equity ratio of 1.06. H. B. Fuller has a 52 week low of $47.56 and a 52 week high of $65.36.

Insider Buying and Selling at H. B. Fuller

In related news, VP Nathan D. Weaver sold 7,075 shares of the company’s stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $58.38, for a total transaction of $413,038.50. Following the completion of the sale, the vice president directly owned 9,441 shares in the company, valued at $551,165.58. This represents a 42.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CFO John J. Corkrean sold 14,222 shares of the firm’s stock in a transaction dated Monday, October 27th. The shares were sold at an average price of $60.31, for a total value of $857,728.82. Following the sale, the chief financial officer directly owned 54,646 shares in the company, valued at approximately $3,295,700.26. The trade was a 20.65% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.99% of the stock is currently owned by company insiders.

Institutional Trading of H. B. Fuller

Hedge funds have recently modified their holdings of the company. Quantinno Capital Management LP grew its position in shares of H. B. Fuller by 137.3% in the 2nd quarter. Quantinno Capital Management LP now owns 9,929 shares of the specialty chemicals company’s stock worth $597,000 after buying an additional 5,745 shares during the last quarter. Cerity Partners LLC lifted its position in H. B. Fuller by 2.3% during the second quarter. Cerity Partners LLC now owns 11,499 shares of the specialty chemicals company’s stock valued at $692,000 after acquiring an additional 261 shares during the last quarter. Baird Financial Group Inc. boosted its stake in H. B. Fuller by 19.6% in the second quarter. Baird Financial Group Inc. now owns 7,518 shares of the specialty chemicals company’s stock valued at $452,000 after acquiring an additional 1,232 shares in the last quarter. Vise Technologies Inc. purchased a new position in H. B. Fuller in the third quarter worth $254,000. Finally, Mercer Global Advisors Inc. ADV acquired a new position in shares of H. B. Fuller during the third quarter worth $229,000. 95.93% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

FUL has been the subject of a number of recent analyst reports. Wall Street Zen lowered shares of H. B. Fuller from a “buy” rating to a “hold” rating in a research note on Monday, November 24th. Seaport Res Ptn upgraded shares of H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday, September 26th. Citigroup raised shares of H. B. Fuller from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $62.00 to $70.00 in a research report on Wednesday, October 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of H. B. Fuller in a research report on Monday, December 29th. Finally, UBS Group started coverage on shares of H. B. Fuller in a research note on Friday, November 21st. They set a “neutral” rating and a $60.00 price target for the company. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, H. B. Fuller has an average rating of “Moderate Buy” and an average price target of $66.20.

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.